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Abstract
Background: The flower bud exudates of Spathodea campanulata is commonly used as a local eye drop in Nigeria and is anecdotally claimed to
improve vision. This study evaluated the anti-cataract activity of Spathodea campanulata (SPCM) flower bud exudates against cataractogenesis using
rat lenses. This was done with a view to providing empirical scientific support for the use of the exudates from SPCM in the treatment and
management of certain eye disorders.
Materials and Methods: Fifty (50) rat lenses were used in this study, i.e. five groups of ten (10) lenses per group. Lenses were incubated in artificial
aqueous humor (Normal control) with simultaneous incubation in 30 mM galactose (Untreated cataract). Co-incubation with captopril (Captopril
treated cataract); 0.1 mg/ml of the exudate (Exudate treated cataract - Low dose) and 0.2 mg/ml of exudate (Exudate treated cataract- High dose)
constituted the study groups. After 72 hr of incubation, lenses were observed for cataract and the preventive potential of the exudate against
cataractogenesis was evaluated through the determination of the levels of anti-oxidant parameters such as total protein (TP), glutathione (GSH),
malondialdehyde (MDA) and activities of superoxide dismutase (SOD) and catalase (CAT) were evaluated in the lens homogenates.
Results: Photographic evaluation of the lenses showed the development of cataract in the untreated cataract group while opacification was retarded in
higher dose exudate-treated and captopril treated lenses. Significant decrease in the levels of GSH and total protein, reduction in SOD and CAT
activities as well as increase in MDA content were observed in cataractous lenses when compared with the normal control. SPCM displayed a dose-
related anti-cataract activity. Captopril showed comparable anti-cataract potential to (0.2 mg/ml) SPCM. GSH, SOD and CAT activity in captopril
treated cataract lenses increased to 75.55%, 64.08% and 72.45% of the normal control values respectively. In (0.2 mg/ml) exudate treated cataract
lenses; GSH, SOD and CAT activity increased to 57.7%, 76.69% and 80.61% respectively.
Conclusion: The study concluded that exudate of SPCM elicited its anti-cataract potential through its anti-oxidant activities.
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Introduction
Cataract is a major cause of blindness in the world (Shichi, 2004). It is estimated that about 41.8% of blindness in the world is caused by
cataract with a higher incidence in developing countries (Shakil et al., 2008).
Cataract is characterized by opacification and breakdown of the micro-architecture in the crystalline eye lens which interferes with the transmission of
light onto the retina (Umamaheswari et al., 2012), causing blurriness of near image vision, abnormal color perception, diplopia, impaired vision acuity
(Head, 2001) and hence vision deterioration (Pintor, 2012b).
The target tissue of opacification is the lens which is an avascular tissue having three layers; the outer capsule, the middle cortex and the
inner nuclear layer. Based on this, cataractogenesis is of three main types; the nuclear cataract, the cortical cataract and the posterior sub-capsular
cataract (Patel et al., 2012). In any of these types, the etiology of cataract is diverse and there is difficulty attributing its cause exclusively to a single
factor (Pintor, 2012a). However, risk factors such as socio-economic/educational level, metabolic disorders like diabetes, long-term use of steroids
(Jobling and Augusteyn, 2002; Shakil et al., 2008), smoking (Eman and Elabrak, 2011), nutrition, excessive exposure to sunlight (Zarina et al., 1994)
and aging (Kisic et al., 2012) may play a role. Moreover, studies over the years have established oxidative stress as a major factor that triggers
cataractogenesis (Williams, 2006; Babizhaye et al., 2010) with lipid peroxidation products in the lens correlating with opacity (Marsili et al., 2004).
Lipid peroxidation may be triggered by endogenous and exogenous insults such as reactive oxygen species (ROS), metal ions, ultraviolet irradiations
and drugs (Kisic et al., 2012). Peroxidation of biomolecules such as the lens membrane lipids and proteins compromise the structure and functions of
these molecules leading to increased permeability and change in the lens micro-environment (Kisic et al., 2012). Due to osmotic imbalance, the lens
becomes hydrated (Kinoshita, 1974) resulting in refractive index fluctuation, electrolyte imbalance (Kisic et al., 2012) and oxidation and precipitation
of proteins (Head, 2001).
Under hyperglycemic conditions, proteins undergo glycation (Kyselova et al., 2004; Patel, 2012). Ocular tissues however contain
antioxidants (enzymatic and non-enzymatic) that prevent oxidative damages (Kisic et al., 2012) but when these barriers are broken, cataract develops.
The only treatment available is the surgical removal of the lens with artificial replacement as there is no other effective means of treatment (Zarina et
al., 1994). Even drugs that were developed to delay or prevent opacification have failed to give convincing results when tested (Marsili et al., 2004).
Although cataract surgery is highly effective, the limited number of surgeons especially in developing countries is a major limitation (Kyselova et al.,
2004).
Again, the high cost of surgery coupled with complications such as bleeding (hyphema), lens capsule rupture, loss of the vitreous humor, iris
detachment and opacification of the posterior capsule afterwards have made surgery non-efficient (Marcantonio and Vrensen, 1999). There is
therefore a need to explore non-surgical interventions.
Spathodea campanulata, also known as the African tulip tree, fountain tree or the flame of the forest is widely used as an ornamental plant (Trigo and
Santos, 1998; Zaheer et al., 2011). The extracts of leaves, stem bark, flower and roots are used in ethno-medicine for the treatment of various diseases
Adio et al., Afr J Tradit Complement Altern Med. (2014) 11(6):83-91
http://dx.doi.org/10.4314/ajtcam.v11i6.9
84
(Ofori-kwakye, 2011). The exudate from the flower bud is applied to the eye and has been claimed to improve vision and prevent eye diseases. There
is however no empirical scientific study to back up these claims, as a result this study.
Materials and Methods
Reagents and Chemicals
The reference drug, captopril, was procured from a Registered Pharmacy in Ile-Ife. Other reagents and chemicals used including 5,5’-dithio-
bis-nitrobenzenzoic acid, adrenalin, reduced glutathione, Bovine serum albumin, ascorbic acid, quercetin, gallic acid, 2,2-diphenyl-2-picrylhydrazyl
hydrate (DPPH), ferric chloride, 2, 4, 6-tri-(2-pyridyl)-1, 3, 5-triazine (TPTZ), ammonium molybdate and hydrogen peroxide were of analytical grade
obtained either from Sigma Aldrich, St. Louis, USA or British Drug House (BDH) Limited, Poole, England
Plant Material
Fresh flower buds of Spathodea campanulata were collected from a tulip tree at Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
The plant was identified at IFE Herbarium with the voucher number (17227). The buds exudate was collected by cutting off the tip of the bud and
pressing to release the exudate into a brown bottle. It was then kept at 4°C prior to use.
Experimental Animals
Healthy White Albino rats (25) of either sex (80-110kg) were purchased from the animal holding facility of the college of Health Sciences,
Obafemi Awolowo University, Ile-Ife, Nigeria. The animals were acclimatized for one week and fed with standard rat chow (purchased from Ladokun
Feeds, Ibadan, Nigeria) and water ad libitum.
Collection of Eye Balls of Rats
Animals were euthanized under light chloroform anesthesia with the eyeballs removed from the eye socket by dissection. The lenses were
carefully removed using posterior approach to prevent damage to the lens capsules.
Culturing of Lens and Cataract Induction
The lenses were incubated in artificial aqueous humor (140mM NaCl, 5mM KCl, 2mM MgCl2, 0.5mM NaHCO3, 0.5mM Na2HPO4, 0.4mM
CaCl2, and 5mM Glucose, pH of 7.8) for 72 hours in an incubating chamber at room temperature. Added to the artificial aqueous humor were 100
μg/ml of streptomycin and 100 IU/ml of penicillin to prevent bacterial contamination. All culturing equipments were made sterile with the culturing 
media autoclaved and changed every 24h throughout the incubation period. Galactose (30 mM) served as cataract inducer (Malone et al., 1993).
Study Groups
Eye lenses were randomly sorted into 5 groups of 10 lenses each and treated as follows:
Group 1: Lens + Artificial aqueous humor (AAH) (Normal Control- NC)
Group 2: Lens + AAH + 30 mM Galactose (Untreated Cataract- UC)
Group 3: Lens + AAH + 30 mM Galactose+ 5 mM Captopril (Captopril treated cataract- CC)
Group 4: Lens + AAH + 30 mM Galactose+ 0.1 mg/ml exudate (Exudate treated cataract- Low Dose- LD)
Group 5: Lens + AAH + 30 mM Galactose+ 0.2 mg/ml exudate (Exudate treated cataract-High
Dose- HD)
* Captopril is a synthetic 3-mercapto-2-methylpropionyl derivative of L-proline, reported to possess anticataract potential (Lakshmi et al., 2009) and is
one of the most commonly used drugs in treatment of cataract.
Photographic Evaluation
After 72 hours of incubation, lenses were mounted and observed for opacity by placing the lenses on a grid. The pattern of the grid observed
through the lens using a Durst enlarger at a magnification of Х6.5.
Preparation of Lens Homogenates
Lenses (10) were homogenized in 10% (w/v) of 0.1 M potassium phosphate buffer at pH 7.0. The homogenate was centrifuged at 10,000
rpm (Centurion Scientific Ltd U.K; R-1880) at 4°C for 1 h. The supernatants were collected and used for estimation of biochemical parameters.
Phytochemical Screening and Antioxidant Analyses of the Exudate
The flower bud exudate was subjected to phytochemical screening using standard procedure earlier described by Sofowora (1993), Trease
and Evans (2002) and Nayak and Pereira (2006).
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The flavonoid content was determined using aluminium chloride reaction method of Zhilen et al. (1999) as described by Miliauskas et al. (2004) and
the total phenolic content was determined using the method of Singleton and Rossi (1965) as described by Gulcin et al. (2003).
The antioxidant potentials of the exudate were evaluated using the total antioxidant activity and ferric reducing antioxidant power (FRAP) assays as
described by Prieto et al. (1998), and Benzie and Strain (1999) respectively. The radical scavenging ability of the exudate was determined using the
stable 2,2-diphenyl-2-picrylhydrazyl hydrate (DPPH) radical (Brand-Williams et al., 1995).
Reduced glutathione was determined by the method of Moron et al. (1979) and total protein content was determined using the Lowry method (Lowry
et al., 1951). The degree of oxidative stress was assessed by measuring malondialdehyde (MDA) levels by TBARS-method (Parihar and Taruna,
2003), Superoxide dismutase (SOD) activity (Misra and Fridovich, 1972) and catalase activity (Rocha et al., 2003).
Statistical Analysis
All data were expressed as mean ± SEM of n=3 readings. Difference between mean values was determined by One-way Analysis of
Variance (ANOVA) followed by Tukey post-test and differences with p< 0.05 were considered significant.
Results
Phytochemical Screening of the exudate revealed the presence of alkaloids, flavonoids, saponin, cardiac glycosides and triterpenoids in trace
amount while anthraquinones and tannins were not detected.
Evaluation of in vitro Antioxidant Potentials of the Exudate
The total flavonoids and total phenolic contents of the exudate were 2.80±0.16 mgQE/g of exudate (QE= quercetin equivalent) and
22.67±0.33 mgGAE/g of exudate (GAE= Gallic acid equivalent) respectively. The exudate and the standard antioxidant, ascorbic acid, exhibited a
concentration-dependent inhibition of DPPH radical. The IC50 values for ascorbic acid and the exudate were 7.27 μg/ml and 61.8 μg/ml respectively. 
The reducing power of the exudates as indicated by the ferric Reducing Antioxidant Power assay was 23.33±0.33 mgAAE/g of exudate (AAE=
Ascorbic acid equivalent) and the total antioxidant capability was 27.333±0.67 mgAAE/g of exudate.
Photographic Evaluation
Photographic evaluation after 72 hours of incubation showed that the untreated cataract group developed opacity (Plate 1B). Compared to
the normal control (Plate 1A), captopril treated cataract (Plate 1C) and 0.2 mg/ml SPCM (Plate 1E) treated cataract lenses retained a comparable
degree of transparency. Captopril and SPCM (0.2 mg/ml) were able to protect or retard cataractogenesis while 0.1 mg/ml SPCM (Plate 1D) showed a
lower potency to protect against cataract development.
Biochemical Parameters
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Figure 1: Concentrations of Total Protein in Normal, Untreated and Treated Rat Lenses
Values represent mean ±SEM, n= 3 readings. #p<0.05 when compared to untreated cataract
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Figure 1 is the summary of total protein concentrations in lenses across the treatment groups. The protein concentration of the untreated cataract group
decreased to 85.56% of the normal control value. Treatment with captopril increased protein concentration to 94.06% of the normal control value.
SPCM exudate at the lower and higher doses increased protein concentration to 101.49% and 112.86% of normal control value respectively.
Plate 1: Representative Photographs of Normal and Treated Lenses
(A)Normal control; (B) Untreated cataract; (C) Captopril treated cataract; (D) Exudate treated cataract- Low dose; (E) Exudate treated cataract- High
dose.
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NC= Normal Control; UC= Untreated Cataract; CC= Captopril Treated Cataract; LD= Exudate Treated Cataract- Low Dose; HD= Exudate Treated
Cataract- High Dose
Figure 2: Concentrations of Reduced Glutathione in Normal, Untreated and Treated Rat Lenses
Values represent mean ± SEM, n= 3 readings. *p< 0.05 when compared to normal control; #p<0.05 when compared to untreated cataract
Figure 2 is the summary of reduced glutathione concentrations in lenses of the different treatment groups. The reduced glutathione concentration
dropped to 24.44% of normal control value. Captopril, SPCM at 0.2 mg/ml and 0.1 mg/ml protected the lenses and increased the reduced GSH
concentration to 75.55%, 57.7% and 42.22% of the normal control value respectively.
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*NC= Normal Control; UC= Untreated Cataract; CC= Captopril Treated Cataract; LD= Exudate Treated Cataract- Low Dose; HD= Exudate Treated
Cataract- High Dose
Figure 3: Catalase Activity in Normal, Untreated and Treated Rat Lenses
Values represent mean ± SEM, n= 3 readings. *p<0.05 when compared to normal control;
#p< 0.05 when compared to untreated cataract
Fig. 3 is the summary of catalase activity in lenses across the different treatment groups. In untreated cataract lens, catalase activity dropped to 25.51%
of the normal controls. Treatment with captopril resulted in increased activity to 72.45% of normal control value. Treatment with SPCM resulted in
catalase activities of 63.27% and 80.61% of normal control value at the lower and higher doses respectively.
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*NC= Normal Control; UC= Untreated Cataract; CC= Captopril Treated Cataract; LD= Exudate Treated Cataract- Low Dose; HD= Exudate Treated
Cataract- High Dose
Figure 4: Superoxide Dismutase Activity in Normal, Untreated and Treated Rat Lenses
Values represent mean ± SEM, n= 3 readings. *p< 0.05 when compared to normal control
Figure 4 is the summary of superoxide dismutase activity in lenses across the different treatment groups. SOD activity of the untreated cataract lenses
decreased to 50.49% of normal controls. Treatment with captopril resulted in activity of 64.08% of normal control lenses. Cataractous lenses treated
with the lower and higher doses of SPCM however had activities of 61.17% and 76.69% of normal control value respectively.
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*NC= Normal Control; UC= Untreated Cataract; CC= Captopril Treated Cataract; LD= Exudate Treated Cataract- Low Dose; HD= Exudate Treated
Cataract- High Dose
Figure 5: Lipid Peroxidation (Malondialdehyde) in Normal, Untreated and Treated Rat Lenses
Values represent mean ± SEM, n= 3 readings. *p< 0.05 when compared to normal control;
#p< 0.05 when compared to untreated cataract.
Figure 5 is the summary of malondialdehyde concentrations in lenses across the different treatment groups. Significant increase (to 300% of the
normal control value) in MDA level was seen in the untreated cataract lenses. The anti-cataract activity of Captopril and SPCM 0.2 mg/ml protected
the lenses against lipid peroxidation by increasing concentration of MDA to 142.86% and 171.43% of the normal control value respectively. The
increase was to 214% of the normal control value in SPCM 0.1 mg/ml treated cataract lenses.
Discussion
The sense organ for vision, the eye, is the most complex organ of the five sense organs of the human body (Segre, 2014). It is responsible for
collection of light rays, focusing it on the retina and encoding the neural signal sent to the brain for interpretation (Prasad and Gelatta, 2011). For the
eye to perform these functions effectively the lens has to remain transparent. However, in cataract, the crystalline eye lens is opacified leading to the
loss of transparency. Among the various experimental models used in cataractogenesis studies, the sugar-induced cataract model is used in this study
as it is a commonly used model that assumes that factors initiating galactose-induced cataracts in young rats are similar to those involved in the human
sugar-cataract model (Kinoshita, 1965). The underlying mechanisms in sugar-induced cataract are becoming unraveled. Galactose is reduced to
galactitol by the aldose reductase and causes hydration of the eye which eventually leads to osmotic stress (Patterson and Bunting, 1965; Kinoshita,
1974; Lakshmi and Sharma, 2011), thereby causing enzyme inactivation (such as Na+ K- ATPase), loss of membrane integrity, refractive index
fluctuations and loss of protein functions (Kisic et al., 2012). These effects are further aggravated by increased hydration due to high concentration of
protein in the lens (Patterson and Bunting, 1965). Earlier studies have also implicated glycation of lens proteins (as measured by the protein carbonyl
content as well as the concentration of glycation products) in nuclear lens protein, which was found to be higher in cataractous lens (Lyons et al.,
1991, Suryanarayana et al., 2007).
Cross-linking and aggregation of proteins, considered to be a major change that results in lens opacification has been reported in sugar-
induced cataract (Luthra and Balasubramania, 1993) with subsequent formation and accumulation of advanced glycation end-products which itself is a
pro-oxidant (Luthra and Balasubramania, 1993; Hsu and Zimmer, 2010). This preoxidant and other free radicals generated through auto-oxidation of
sugars lead to oxidative stress (Jyothi et al., 2003; Marsili et al., 2004; Gupta et al., 2009) to which the lens is highly susceptible (Sasikala et al., 2010).
Previous studies established oxidative stress as a triggering factor in the development of cataract (Williams, 2006) with augmentation of the
antioxidant defenses of the lens seen to prevent or delay cataractogenesis (Spector, 1995).
In this study, antioxidant property of Spathodea campanulata flower bud exudate was examined with the total phenolic and flavonoid
contents quantified. This study revealed total phenolic and total flavonoid concentrations of 22.67 mgGAE/g exudate and 2.80 mgQE/g exudate
respectively. Vijayasanthi and Kannan (2013) previously reported S. campanula leaves to have a total phenolic and flavonoid content of 162
mgGAE/g dry materials and 61.23 mgQE/g dry materials respectively in the aqueous extract. However, Trigonella foenum-graecum seed previously
shown to possess anti-cataract activity (Gupta et al., 2009) was seen to have a total phenolic content of 6.85 mgGAE/g of seed and a total flavonoid
content 0.65 mgQE/g of seed (Bukhari et al., 2008) which is lower than that of S. campanulata flower bud exudate. Generally, polyphenols are widely
studied for their antioxidant properties (Perron and Brumaghim, 2009) and there are quite a number of methods used for evaluating antioxidant
activity of plants. Among these, 2,2-diphenyl-2-picrylhydrazyl hydrate (DPPH) scavenging assay, ferric reducing power assay and total antioxidant
assay were used in this study.
DPPH is a commercially available radical which upon reduction by an anti-oxidant has its purple color fading, an outcome that is measured
spectrophotometrically. DPPH scavenging assay of the exudate showed concentration dependent inhibition of DPPH radical, with the scavenging
ability increasing with increasing concentration. The IC50 (concentration at which the exudate causes 50% inhibition of DPPH radical) of the exudate
was found to be 64.91 μg/ml while the reference ascorbic acid standard had an IC50 of 7.27 μg/ml. Since a low IC50 value indicates strong antioxidant
activity (Duganath, 2010), it could be concluded that the exudate was about nine (9) times less active than ascorbic acid in transfer of hydrogen ions to
oxidants. This activity is however, still remarkable, considering that a previous study measuring the DPPH radical scavenging activity of extracts of
the flower of S. campanulata reported an IC50 value of 225 µg/ml (Hareesh et al., 2010).
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Determination of the flower bud exudates’ ability to reduce ferric (III) iron to ferrous (II) iron and molybdenum (VI) to molybdenum (V)
using ferric reducing antioxidant power (FRAP) assay and total antioxidant assay respectively were investigated. The exudate showed a concentration
of 23.33 mg ascorbic acid equivalent per gram of exudate in reducing ferric (III) iron to ferrous (II) iron and 27.33 mg ascorbic acid equivalent per
gram of exudate in reducing molybdenum (VI) to molybdenum (V).
The exudate was screened for the presence of plant secondary metabolites. The analysis revealed absence of anthraquinones and tannins
while alkaloids, flavonoids, saponin, glycosides and triterpenoids were found present. Screening of S. campanulata flowers and leaves showed that the
flower and leaves had steroids and tannins in addition to phytochemicals present in the exudate (Hareesh et al., 2010; Ilodigwe et al., 2010; Kowti et
al., 2010). Ilodigwe et al. (2010) however found anthraquinone present in the ethanolic leaf extract. Screening of the flower base fluid of S.
campanulata was equally positive for steroids while alkaloids, tannins and triterpenoids were absent (Killedar et al., 2011). Generally, phytochemicals
are biologically active compounds some of which are known to have antioxidant effect (Akinmoladun et al., 2007)
In this study, cataract was successfully induced by culturing the lenses in media containing 30 mM galactose (Plate 1B). Captopril at a
concentration of 5 mM and S. campanulata at 0.2 mg/ml concentrations offered protection against cataract development or retarded the process of
cataractogenesis (Plate 1C and 1E). Photographic evaluation of the low dose (0.1 mg/ml) treated cataract lens however showed a lower degree of
transparency (Plate 1D) when compared to the control, captopril and the high dose treated cataract lenses. Thus, indicating a lower potency to protect
against cataract development. The results of the photographic evaluation of the lenses, showing a dose related protection, are further supported by the
results from the biochemical assays.
Malondialdehyde, an indicator of lipid peroxidation was found to be higher in the untreated cataract group (300% of the normal control
value) and 0.1 mg/ml SPCM-treated cataract group (214% of the normal control value) compared to other test groups (Fig. 5). The increase might
have been caused by increased lipid peroxidation. The result was similar to the observations of Jyothi et al. (1993) in a study tracking peroxidation in
premature, mature and hypermature galactogenic cataract model. Increased MDA concentrations in cataractogenic models have been previously
reported in in vivo and in vitro studies (Nair 2010; Umamaheswari et al., 2012). Lipid peroxidation is regarded as a pathogenic factor of
cataractogenesis (Kisic et al., 2012) that could be induced by reactive oxygen species or oxygen radicals. Significant decrease in malondialdehyde
concentrations of SPCM (0.2 mg/ml) and captopril (5 Mm) treated cataract groups is an indication of protection against peroxidation with the
possibility of preserved structural integrity of the lens fibre membranes.
The protein concentration of the untreated cataract group decreased to 85.56% of the normal control value (Fig. 1). Earlier, reduction to
89.26% and 81.1% of the normal control lenses in premature and mature galactose-induced cataract in vivo has been reported by Jyothi et al. (2003).
The reduction might be attributed to fragmentation and subsequent leakage of proteins due to the disruption of the lens fibre membranes. Intact lens
capsule is a semi permeable membrane shown to be impermeable to large protein. This permeability pattern is altered in cataract (Patterson and
Bunting, 1965). Increase in protein concentration by captopril and SPCM (0.2 mg/ml) implies that they mitigated protein damages; which is an
important factor for maintaining or restoring lens transparency. However, SPCM at the lower dose of 0.1 mg/ml was not significantly protective.
GSH is a major antioxidant in the lens known to be present at a very high concentration (Javadzadeh et al., 2009; Kisic et al., 2012; Hui-Ping et al.,
2013). Its maintenance has been reported to be vital for lenticular transparency (Isai et al., 2009) as it scavenges damaging radicals and reduces
lenticular proteins by means of its sulfhydryl groups thereby preventing cross-linking and aggregation (Isai et al., 2009; Javadzadeh et al., 2009;
Rooban et al., 2009). Evaluation of the level of reduced glutathione in the present investigation showed a reduction to 24.44% of normal control value
in the untreated cataract group. The reduction might be attributed to increased binding of GSH to oxidized lens proteins, scavenging of the excess
ROS and change in some part of the system that governs GSH-GSSG interchange and formation. Similar decrease to 26.4% was observed by Lakshmi
and Sharma, (2011) while Gupta et al. (2009) observed decrease to 40.5% when 30% galactose added to the diet was used as cataract inducer.
Generally, decrease in the amount of glutathione content of cataractogenic lenses has been reported (Harding, 1970; Özmen et al., 2000; Head, 2001).
In this study, SPCM restored the depleted glutathione in a dose related manner to 57.7% and 42.22% of the normal control value respectively. The
activity was comparable to captopril treated cataract group which also restored (75.55%) glutathione depletion.
Ocular tissue possesses enzymatic antioxidant defenses such as superoxide dismutase and catalase, capable of catalytic removal of free
radicals and other reactive species (Hui-Ping et al., 2012; Yang et al., 2013). Significant decrease in superoxide dismutase and catalase activities of the
untreated cataract group compared to the normal control group as observed in this present investigation was an indication of increased oxidative stress
with subsequent utilization of these enzymes. This was in line with previous studies showing that reported decreased enzyme activity in
cataractogenesis (Awasthi et al., 1996). Jyothi (2003) observed 43.40% and 36.61% reduction in superoxide dismutase and catalase activities
respectively as against 50.49% and 25.51% obtained in this study. Captopril and Spathodea campanulata exudate at the higher concentration protected
the lenses and elevated the activities of these enzymes with their relative activities comparable. However, at lower dosage of SPCM lens treatment, no
significant difference was observed in enzyme activities which indicated that SPCM (0.1mg/ml) possesses very little potential to protect the lens
against cataractogenesis.
Conclusion
In conclusion, spathodea campanulata flower bud exudate contains bioactive molecules that possess anti-cataract activity and protected the
wistar rat lenses from galactose induced cataractogenesis as evidenced by the morphological assessment of the lenses and evaluation of various
biochemical parameters of the lens.
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